Business Segments · Selling, general and administrative expenses

Research & Development Solutions — Selling, general and administrative expenses

IQVIA Research & Development Solutions — Selling, general and administrative expenses increased by 11.6% to $250.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.7%, from $216.00M to $250.00M. Over 4 years (FY 2021 to FY 2025), Research & Development Solutions — Selling, general and administrative expenses shows an upward trend with a 3.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026
Rolls up toSG&A

How to read this metric

An increase relative to revenue may suggest rising administrative overhead or investment in sales infrastructure, while a decrease indicates successful cost-containment or improved operating leverage.

Detailed definition

Includes the overhead costs required to support the research and development segment, such as administrative salaries, o...

Peer comparison

Standard SG&A metric used across all industries to measure administrative efficiency.

Metric ID: iqv_segment_research_development_solutions_selling_general_and_administrative_expenses

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$193.00M$198.00M$201.00M$211.00M$204.00M$199.00M$217.00M$212.00M$211.00M$217.00M$211.00M$221.00M$223.00M$222.00M$215.00M$216.00M$227.00M$232.00M$224.00M$250.00M
QoQ Change+2.6%+1.5%+5.0%-3.3%-2.5%+9.0%-2.3%-0.5%+2.8%-2.8%+4.7%+0.9%-0.4%-3.2%+0.5%+5.1%+2.2%-3.4%+11.6%
YoY Change+5.7%+0.5%+8.0%+0.5%+3.4%+9.0%-2.8%+4.2%+5.7%+2.3%+1.9%-2.3%+1.8%+4.5%+4.2%+15.7%
Range$193.00M$250.00M
CAGR+5.6%
Avg YoY Growth+3.9%
Median YoY Growth+3.8%

Frequently Asked Questions

What is IQVIA's research & development solutions — selling, general and administrative expenses?
IQVIA (IQV) reported research & development solutions — selling, general and administrative expenses of $250.00M in Q1 2026.
How has IQVIA's research & development solutions — selling, general and administrative expenses changed year-over-year?
IQVIA's research & development solutions — selling, general and administrative expenses increased by 15.7% year-over-year, from $216.00M to $250.00M.
What is the long-term trend for IQVIA's research & development solutions — selling, general and administrative expenses?
Over 4 years (2021 to 2025), IQVIA's research & development solutions — selling, general and administrative expenses has grown at a 3.7% compound annual growth rate (CAGR), from $777.00M to $899.00M.
What does research & development solutions — selling, general and administrative expenses mean?
The overhead and administrative costs required to run the clinical research business segment.